Concord Drugs Limited (CONCORD.BO)
INR 29.95
(0.0%)
INR 29.95
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.72 Million INR | -52.06% |
| 2022 | 9.85 Million INR | -38.19% |
| 2021 | 15.94 Million INR | -51.42% |
| 2020 | 32.81 Million INR | 899.6% |
| 2019 | 3.28 Million INR | -19.34% |
| 2018 | 4.07 Million INR | 25.58% |
| 2017 | 3.24 Million INR | 103.2% |
| 2016 | 1.59 Million INR | -90.88% |
| 2015 | 17.48 Million INR | 151.04% |
| 2014 | 6.96 Million INR | 105.6% |
| 2013 | 3.38 Million INR | -67.46% |
| 2012 | 10.41 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 273 Thousand INR | 108.06% |
| 2023 FY | 4.72 Million INR | -52.06% |
| 2023 Q4 | -3.38 Million INR | -40.46% |
| 2023 Q3 | -2.41 Million INR | -142.93% |
| 2023 Q2 | 5.61 Million INR | 14.54% |
| 2023 Q1 | 4.9 Million INR | 201.29% |
| 2022 Q4 | 1.62 Million INR | -64.16% |
| 2022 FY | 9.85 Million INR | -38.19% |
| 2022 Q3 | 4.54 Million INR | 150.58% |
| 2022 Q2 | 1.81 Million INR | -3.26% |
| 2022 Q1 | 1.87 Million INR | 586.51% |
| 2021 Q1 | 6.87 Million INR | 103.94% |
| 2021 Q2 | 4.58 Million INR | -33.4% |
| 2021 Q4 | 272.97 Thousand INR | -93.52% |
| 2021 Q3 | 4.21 Million INR | -7.99% |
| 2021 FY | 15.94 Million INR | -51.42% |
| 2020 Q4 | 3.37 Million INR | -87.5% |
| 2020 FY | 32.81 Million INR | 899.6% |
| 2020 Q3 | 26.98 Million INR | 3245.4% |
| 2020 Q1 | 1.65 Million INR | 77.47% |
| 2020 Q2 | 806.6 Thousand INR | -51.23% |
| 2019 FY | 3.28 Million INR | -19.34% |
| 2019 Q2 | 565 Thousand INR | -57.93% |
| 2019 Q4 | 932 Thousand INR | 110.38% |
| 2019 Q3 | 443 Thousand INR | -21.59% |
| 2019 Q1 | 1.34 Million INR | -67.0% |
| 2018 Q2 | 373 Thousand INR | -70.81% |
| 2018 FY | 4.07 Million INR | 25.58% |
| 2018 Q4 | 4.07 Million INR | 1005.98% |
| 2018 Q1 | 1.27 Million INR | 196.02% |
| 2018 Q3 | 368 Thousand INR | -1.34% |
| 2017 Q1 | -99 Thousand INR | 99.44% |
| 2017 FY | 3.24 Million INR | 103.2% |
| 2017 Q4 | -1.33 Million INR | -137.36% |
| 2017 Q3 | 3.56 Million INR | 503.9% |
| 2017 Q2 | 590 Thousand INR | 695.96% |
| 2016 Q1 | 1.12 Million INR | -78.51% |
| 2016 FY | 1.59 Million INR | -90.88% |
| 2016 Q3 | 13.23 Million INR | 281.72% |
| 2016 Q4 | -17.76 Million INR | -234.19% |
| 2016 Q2 | 3.46 Million INR | 207.17% |
| 2015 Q4 | 5.25 Million INR | -71.9% |
| 2015 Q2 | 2.45 Million INR | 10.78% |
| 2015 Q1 | 2.21 Million INR | 573.35% |
| 2015 FY | 17.48 Million INR | 151.04% |
| 2015 Q3 | 18.69 Million INR | 660.97% |
| 2014 Q1 | 1.17 Million INR | 24.07% |
| 2014 FY | 6.96 Million INR | 105.6% |
| 2014 Q4 | 329.4 Thousand INR | -74.25% |
| 2014 Q3 | 1.27 Million INR | 4.58% |
| 2014 Q2 | 1.22 Million INR | 4.53% |
| 2013 Q3 | 872 Thousand INR | 3.93% |
| 2013 Q2 | 839 Thousand INR | 14.15% |
| 2013 Q4 | 943 Thousand INR | 8.14% |
| 2013 FY | 3.38 Million INR | -67.46% |
| 2013 Q1 | 735 Thousand INR | -80.95% |
| 2012 FY | 10.41 Million INR | 0.0% |
| 2012 Q4 | 3.85 Million INR | 62.15% |
| 2012 Q3 | 2.38 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ANG Lifesciences India Limited | -101.43 Million INR | 104.657% |
| Add-Shop E-Retail Limited | 31.57 Million INR | 85.037% |
| Bacil Pharma Limited | -590.53 Thousand INR | 899.959% |
| Beryl Drugs Limited | 7.68 Million INR | 38.538% |
| Cian Healthcare Limited | 2.54 Million INR | -85.765% |
| Colinz Laboratories Limited | 4.86 Million INR | 2.938% |
| Deccan Health Care Limited | 14.92 Million INR | 68.351% |
| Gennex Laboratories Limited | 131.75 Million INR | 96.414% |
| Gujarat Terce Laboratories Limited | 2.43 Million INR | -94.084% |
| Ishita Drugs and Industries Limited | 7.48 Million INR | 36.887% |
| Kerala Ayurveda Limited | -15.27 Million INR | 130.934% |
| Kwality Pharmaceuticals Limited | 237.96 Million INR | 98.015% |
| Mercury Laboratories Limited | 56.54 Million INR | 91.645% |
| Panchsheel Organics Limited | 141.07 Million INR | 96.651% |
| Parmax Pharma Limited | -1.04 Million INR | 553.934% |
| Parnax Lab Limited | 96.09 Million INR | 95.084% |
| Patidar Buildcon Limited | -956 Thousand INR | 594.142% |
| Pharmaids Pharmaceuticals Limited | -79.68 Million INR | 105.929% |
| Phaarmasia Limited | -5.18 Million INR | 191.162% |
| Sandu Pharmaceuticals Limited | 14.61 Million INR | 67.67% |
| Sastasundar Ventures Limited | 88.82 Million INR | 94.682% |
| SHELTER PHARMA LIMITED | 62 Million INR | 92.381% |
| Source Natural Foods and Herbal Supplements Limited | 17.36 Million INR | 72.796% |
| SUDARSHAN PHARMA INDUSTRIES LI | 114.55 Million INR | 95.876% |
| Sunil Healthcare Limited | -17.88 Million INR | 126.413% |
| Syschem (India) Limited | 27.61 Million INR | 82.893% |
| Trident Lifeline Limited | 63.43 Million INR | 92.553% |
| Transchem Limited | 42.03 Million INR | 88.761% |
| Tyche Industries Limited | 122.42 Million INR | 96.141% |
| Vikram Thermo (India) Limited | 253.78 Million INR | 98.139% |
| Vasundhara Rasayans Limited | 58.59 Million INR | 91.938% |
| Zenith Healthcare Limited | 2.03 Million INR | -132.138% |
| Zenotech Laboratories Limited | 82.98 Million INR | 94.308% |
| Hindustan Bio Sciences Limited | 575.94 Thousand INR | -720.223% |
| KIMIA BIOSCIENCES LIMITED | -53.08 Million INR | 108.899% |
| Chemo Pharma Laboratories Limited | 12 Million INR | 60.646% |
| MedPlus Health Services Limited | 654.73 Million INR | 99.278% |
| Sanjivani Paranteral Limited. | 61.65 Million INR | 92.338% |
| Smruthi Organics Limited | 35.9 Million INR | 86.842% |
| Trimurthi Limited | 104 Thousand INR | -4442.308% |
| Zenlabs Ethica Limited | 4.21 Million INR | -12.156% |
| Makers Laboratories Limited | -62.64 Million INR | 107.541% |
| Lactose (India) Limited | 67.89 Million INR | 93.042% |
| Bharat Immunologicals & Biologicals Corporation Limited | -166.38 Million INR | 102.839% |
| Roopa Industries Limited | 15.19 Million INR | 68.903% |
| PANJON LTD. | 1.51 Million INR | -211.937% |
| TIAAN CONSUMER LIMITED | -23.81 Million INR | 119.84% |
| Anuh Pharma Limited | 600.57 Million INR | 99.213% |
| Crestchem Limited | 21.46 Million INR | 77.99% |
| Emmessar Biotech & Nutrition Limited | 7.49 Million INR | 36.98% |
| PRAVEG LIMITED | 129.99 Million INR | 96.366% |
| Fredun Pharmaceuticals Limited | 156.23 Million INR | 96.976% |
| Shukra Pharmaceuticals Limited | 185.37 Million INR | 97.452% |
| Norris Medicines Limited | -11.86 Million INR | 139.806% |
| Denis Chem Lab Limited | 111.55 Million INR | 95.765% |
| Veerhealth Care Limited | 4.06 Million INR | -16.355% |
| Jenburkt Pharmaceuticals Limited | 259.77 Million INR | 98.181% |
| OXYGENTA PHARMACEUTICAL LIMITE | -34.79 Million INR | 113.577% |
| Godavari Drugs Limited | 55.48 Million INR | 91.487% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 1263.547% |
| Ambalal Sarabhai Enterprises Limited | 56.8 Million INR | 91.684% |
| Vivanza Biosciences Limited | 5.47 Million INR | 13.685% |
| Medi-Caps Limited | -22.4 Million INR | 121.082% |
| DECIPHER LABS LIMITED | -16.75 Million INR | 128.193% |
| Shree Ganesh Remedies Limited | 281.08 Million INR | 98.319% |
| Gujarat Themis Biosyn Limited | 591.63 Million INR | 99.202% |
| Bharat Parenterals Limited | 145.17 Million INR | 96.746% |
| BDH Industries Limited | 98.67 Million INR | 95.213% |
| Vista Pharmaceuticals Limited | -45.12 Million INR | 110.47% |
| Coral Laboratories Limited | 157.89 Million INR | 97.008% |
| Evoq Remedies Limited | 4.52 Million INR | -4.421% |
| Trinity League India Limited | -27.07 Million INR | 117.45% |
| KOBO BIOTECH LIMITED | -49.28 Million INR | 109.584% |
| Natural Capsules Limited | 55.53 Million INR | 91.494% |
| Auro Laboratories Limited | 77.92 Million INR | 93.937% |